Code |
Title |
–
|
Top Categories
|
3 |
Administration
|
3E |
Physiological Systems and Anatomical Regions
|
3E0
|
Introduction
Administration, Physiological Systems and Anatomical Regions, Introduction
|
3E01 |
Subcutaneous Tissue
|
3E013 |
Percutaneous
|
3E0130 |
Antineoplastic
|
3E01305
|
Other Antineoplastic
Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
|
3E0130M
|
Monoclonal Antibody
Introduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
|
3E0132 |
Anti-infective
|
3E01328
|
Oxazolidinones
Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach
|
3E01329
|
Other Anti-infective
Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach
|
3E0132A
|
Anti-Infective Envelope
Introduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach
|
3E0133 |
Anti-inflammatory
|
3E0133Z
|
No Qualifier
Introduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach
|
3E0134 |
Serum, Toxoid and Vaccine
|
3E01340
|
Influenza Vaccine
Introduction of Influenza Vaccine into Subcutaneous Tissue, Percutaneous Approach
|
3E0134Z
|
No Qualifier
Introduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach
|
3E0136 |
Nutritional Substance
|
3E0136Z
|
No Qualifier
Introduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach
|
3E0137 |
Electrolytic and Water Balance Substance
|
3E0137Z
|
No Qualifier
Introduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach
|
3E013B |
Anesthetic Agent
|
3E013BZ
|
No Qualifier
Introduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach
|
3E013G |
Other Therapeutic Substance
|
3E013GC
|
Other Substance
Introduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
|
3E013H |
Radioactive Substance
|
3E013HZ
|
No Qualifier
Introduction of Radioactive Substance into Subcutaneous Tissue, Percutaneous Approach
|
3E013K |
Other Diagnostic Substance
|
3E013KZ
|
No Qualifier
Introduction of Other Diagnostic Substance into Subcutaneous Tissue, Percutaneous Approach
|
3E013N |
Analgesics, Hypnotics, Sedatives
|
3E013NZ
|
No Qualifier
Introduction of Analgesics, Hypnotics, Sedatives into Subcutaneous Tissue, Percutaneous Approach
|
3E013T |
Destructive Agent
|
3E013TZ
|
No Qualifier
Introduction of Destructive Agent into Subcutaneous Tissue, Percutaneous Approach
|
3E013V |
Hormone
|
3E013VG
|
Insulin
Introduction of Insulin into Subcutaneous Tissue, Percutaneous Approach
|
3E013VJ
|
Other Hormone
Introduction of Other Hormone into Subcutaneous Tissue, Percutaneous Approach
|